scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing an innovative platform (sc2WearTM Infusor) that may improve patient care and reduce costs to the healthcare system through subcutaneous delivery of IV-equivalent drugs. Our initial products are in heart failure and infectious disease. For further information on how we are transforming the administration of parenteral drugs, go to www.scpharmaceuticals.com.